Cargando…
Metformin Inhibits Gluconeogenesis by a Redox-Dependent Mechanism In Vivo
Metformin, the universal first-line treatment for type 2 diabetes, exerts its therapeutic glucose-lowering effects by inhibiting hepatic gluconeogenesis. However, the primary molecular mechanism of this biguanide remains unresolved, though it has been suggested to act, at least partially, by mitocho...
Autores principales: | Madiraju, Anila K., Qiu, Yang, Perry, Rachel J., Rahimi, Yasmeen, Zhang, Xian-Man, Zhang, Dongyan, Camporez, João-Paulo G., Cline, Gary W., Butrico, Gina M., Kemp, Bruce E., Casals, Gregori, Steinberg, Gregory R., Vatner, Daniel F., Petersen, Kitt Falk, Shulman, Gerald I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6129196/ https://www.ncbi.nlm.nih.gov/pubmed/30038219 http://dx.doi.org/10.1038/s41591-018-0125-4 |
Ejemplares similares
-
Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase
por: Madiraju, Anila K., et al.
Publicado: (2014) -
Metformin, phenformin, and galegine inhibit complex IV activity and reduce glycerol-derived gluconeogenesis
por: LaMoia, Traci E., et al.
Publicado: (2022) -
Glucagon stimulates gluconeogenesis by InsP(3)R-I mediated hepatic lipolysis
por: Perry, Rachel J., et al.
Publicado: (2020) -
Metabolic control analysis of hepatic glycogen synthesis in vivo
por: Nozaki, Yuichi, et al.
Publicado: (2020) -
Validation of a Gas Chromatography-Mass Spectrometry Method for the Measurement of the Redox State Metabolic Ratios Lactate/Pyruvate and β-Hydroxybutyrate/Acetoacetate in Biological Samples
por: Wijngaard, Robin, et al.
Publicado: (2021)